Last 12 months
Inside the activity.
0 purchase rows · 83 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 7 |
| Dec 2025 | 0 | 31 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 27 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 8 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 01, 2019 Filed Nov 1, 2019 20:55 UTC |
RTW INVESTMENTS, LP10% owner
WONG RODERICK10% owner
|
PurchaseCommon Shares | 8,598 | $28.61 | $245,950.09 |
DisclosureSEC source: 0001493152-19-016346 · ownership.xml · nonDerivative · entry 3 RTW INVESTMENTS, LP · CIK 0001493215 · 10% owner WONG RODERICK · CIK 0001493280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By RTW Disclosed balance after: 3,455,809 F2 · price: This transaction was executed in multiple trades at prices ranging from $28.5974 to $28.6215. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the full information regarding the number of shares and prices at which the transaction was effected. F1 · ownership.nature: The securities reported herein may be deemed beneficially owned by each of: (i) RTW Investments, LP ("RTW"), which is deemed the beneficial owner of shares held by RTW Master Fund, Ltd., RTW Venture Fund Limited and RTW Innovation Master Fund, Ltd. (the "Funds"), which are investment funds managed by RTW, and (ii) Roderick Wong, M.D who serves as the Managing Partner and Chief Investment Officer of RTW. Dr. Wong exercises voting and dispositive control over the securities held by RTW and is therefore deemed to be a beneficial owner of securities owned or controlled by RTW. Each of RTW and Dr. Wong disclaim beneficial ownership of the reported securities held by the Funds, except to the extent of its or his pecuniary interest therein. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 20:55 UTC |
RTW INVESTMENTS, LP10% owner
WONG RODERICK10% owner
|
PurchaseCommon Shares | 18,747 | $28.15 | $527,658.69 |
DisclosureSEC source: 0001493152-19-016346 · ownership.xml · nonDerivative · entry 2 RTW INVESTMENTS, LP · CIK 0001493215 · 10% owner WONG RODERICK · CIK 0001493280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By RTW Disclosed balance after: 3,447,211 F1 · ownership.nature: The securities reported herein may be deemed beneficially owned by each of: (i) RTW Investments, LP ("RTW"), which is deemed the beneficial owner of shares held by RTW Master Fund, Ltd., RTW Venture Fund Limited and RTW Innovation Master Fund, Ltd. (the "Funds"), which are investment funds managed by RTW, and (ii) Roderick Wong, M.D who serves as the Managing Partner and Chief Investment Officer of RTW. Dr. Wong exercises voting and dispositive control over the securities held by RTW and is therefore deemed to be a beneficial owner of securities owned or controlled by RTW. Each of RTW and Dr. Wong disclaim beneficial ownership of the reported securities held by the Funds, except to the extent of its or his pecuniary interest therein. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 20:55 UTC |
RTW INVESTMENTS, LP10% owner
WONG RODERICK10% owner
|
PurchaseCommon Shares | 41,438 | $28.79 | $1,193,004.16 |
DisclosureSEC source: 0001493152-19-016346 · ownership.xml · nonDerivative · entry 1 RTW INVESTMENTS, LP · CIK 0001493215 · 10% owner WONG RODERICK · CIK 0001493280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By RTW Disclosed balance after: 3,428,464 F1 · ownership.nature: The securities reported herein may be deemed beneficially owned by each of: (i) RTW Investments, LP ("RTW"), which is deemed the beneficial owner of shares held by RTW Master Fund, Ltd., RTW Venture Fund Limited and RTW Innovation Master Fund, Ltd. (the "Funds"), which are investment funds managed by RTW, and (ii) Roderick Wong, M.D who serves as the Managing Partner and Chief Investment Officer of RTW. Dr. Wong exercises voting and dispositive control over the securities held by RTW and is therefore deemed to be a beneficial owner of securities owned or controlled by RTW. Each of RTW and Dr. Wong disclaim beneficial ownership of the reported securities held by the Funds, except to the extent of its or his pecuniary interest therein. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 17:20 UTC |
RTW INVESTMENTS, LP10% owner
WONG RODERICK10% owner
|
PurchaseCommon Shares | 31,560 | $21.96 | $693,029.20 |
DisclosureSEC source: 0001493152-19-014877 · ownership.xml · nonDerivative · entry 1 RTW INVESTMENTS, LP · CIK 0001493215 · 10% owner WONG RODERICK · CIK 0001493280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By RTW Disclosed balance after: 3,387,026 F1 · ownership.nature: The securities reported herein may be deemed beneficially owned by each of: (i) RTW Investments, LP ("RTW"), which is deemed the beneficial owner of shares held by RTW Master Fund, Ltd. and RTW Innovation Master Fund, Ltd. (the "Funds"), which are investment funds managed by RTW, and (ii) Roderick Wong, M.D who serves as the Managing Partner and Chief Investment Officer of RTW. Dr. Wong exercises voting and dispositive control over the securities held by RTW and is therefore deemed to be a beneficial owner of securities owned or controlled by RTW. Each of RTW and Dr. Wong disclaim beneficial ownership of the reported securities held by the Funds, except to the extent of its or his pecuniary interest therein. Read SEC document |
| September 10, 2019 Filed Sep 13, 2019 00:04 UTC |
Krainer Adrian R.Director
|
GrantDirector Stock Option (Right to Buy) · Derivative | 14,777 | $0.00 Strike: $28.80 | $0.00 |
DisclosureSEC source: 0001567619-19-018220 · doc1.xml · derivative · entry 1 Krainer Adrian R. · CIK 0001780081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,777 Underlying: Common Stock · 14,777 shares Expires 2029-09-09 F1 · derivative.exercise_date: This option vests 100% and becomes exercisable on June 21, 2020, subject to reporting person's continued service through such vesting date. Read SEC document |
| September 10, 2019 Filed Sep 13, 2019 00:10 UTC |
Hall Samuel W.Director · 10% owner
|
GrantDirector Stock Option (Right to Buy) · Derivative | 29,555 | $0.00 Strike: $28.80 | $0.00 |
DisclosureSEC source: 0001567619-19-018224 · doc1.xml · derivative · entry 1 Hall Samuel W. · CIK 0001780090 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,555 Underlying: Common Stock · 29,555 shares Expires 2029-09-09 F1 · derivative.exercise_date: This option shall vest (i) 1/12th of the total shares on June 21, 2019; and then (ii) quarterly as to 1/12th of the total shares, commencing the first quarter following June 21, 2019, subject to Reporting Person's continued service through each vesting date. F2 · ownership.direct: Under the Reporting Person's arrangement with Apple Tree Life Sciences, Inc. (the "Manager"), the Reporting Person holds the option for the benefit of Apple Tree Partners IV, L.P. (the "Fund"). The Reporting Person is obligated to turn over to the Manager any net cash or stock received upon exercise of the option, which will offset advisory fees owed by the Fund to the Manager. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock. Read SEC document |
| September 10, 2019 Filed Sep 13, 2019 00:06 UTC |
LEVIN ARTHUR ADirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 14,777 | $0.00 Strike: $28.80 | $0.00 |
DisclosureSEC source: 0001567619-19-018221 · doc1.xml · derivative · entry 1 LEVIN ARTHUR A · CIK 0001181556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,777 Underlying: Common Stock · 14,777 shares Expires 2029-09-09 F1 · derivative.exercise_date: This option vests 100% and becomes exercisable on June 21, 2020, subject to reporting person's continued service through such vesting date Read SEC document |
| September 10, 2019 Filed Sep 13, 2019 00:11 UTC |
Harrison Seth LoringDirector · 10% owner
|
GrantDirector Stock Option (Right to Buy) · Derivative | 29,555 | $0.00 Strike: $28.80 | $0.00 |
DisclosureSEC source: 0001567619-19-018225 · doc1.xml · derivative · entry 1 Harrison Seth Loring · CIK 0001404955 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,555 Underlying: Common Stock · 29,555 shares Expires 2019-09-09 F1 · derivative.exercise_date: This option shall vest (i) 1/12th of the total shares on June 21, 2019; and then (ii) quarterly as to 1/12th of the total shares, commencing the first quarter following June 21, 2019, subject to Reporting Person's continued service through each vesting date. F2 · ownership.direct: Under the Reporting Person's arrangement with Apple Tree Life Sciences, Inc. (the "Manager"), the Reporting Person holds the option for the benefit of Apple Tree Partners IV, L.P. (the "Fund"). The Reporting Person is obligated to turn over to the Manager any net cash or stock received upon exercise of the option, which will offset advisory fees owed by the Fund to the Manager. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock. Read SEC document |
| September 10, 2019 Filed Sep 13, 2019 00:07 UTC |
TZIANABOS ARTHURDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 14,777 | $0.00 Strike: $28.80 | $0.00 |
DisclosureSEC source: 0001567619-19-018222 · doc1.xml · derivative · entry 1 TZIANABOS ARTHUR · CIK 0001586226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,777 Underlying: Common Stock · 14,777 shares Expires 2029-09-09 F1 · derivative.exercise_date: This option vests 100% and becomes exercisable on June 21, 2020, subject to reporting person's continued service through such vesting date. Read SEC document |
| September 10, 2019 Filed Sep 13, 2019 00:08 UTC |
Burstein JenniferDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 29,555 | $0.00 Strike: $28.80 | $0.00 |
DisclosureSEC source: 0001567619-19-018223 · doc1.xml · derivative · entry 1 Burstein Jennifer · CIK 0001640069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,555 Underlying: Common Stock · 29,555 shares Expires 2029-09-09 F1 · derivative.exercise_date: This option shall vest (i) 1/12th of the total shares on June 21, 2019; and then (ii) quarterly as to 1/12th of the total shares, commencing the first quarter following June 21, 2019, subject to reporting person's continued service through each vesting date. Read SEC document |
| June 21, 2019 Filed Jun 21, 2019 21:01 UTC |
Harrison Seth LoringDirector · 10% owner
|
ConversionSeries B Convertible Preferred Stock · Derivative | 2,799,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013840 · doc1.xml · derivative · entry 7 Harrison Seth Loring · CIK 0001404955 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Apple Tree Partners IV, L. P Disclosed balance after: 0 Underlying: Common Stock · 2,799,910 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · kind: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · derivative.exercise_date: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · derivative.expiration_date: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F2 · ownership.nature: Apple Tree Partners IV, L.P. ("ATP IV"). ATP III GP, Ltd. ("ATP III"), is the sole general partner of ATP IV. Reporting Person is the sole director of ATP III and may be deemed to have sole voting and dispositive power over the shares held by ATP IV. Dr. Harrison disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 21, 2019 Filed Jun 21, 2019 21:01 UTC |
Harrison Seth LoringDirector · 10% owner
|
ConversionSeries A-2 Convertible Preferred Stock · Derivative | 7,617,746 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013840 · doc1.xml · derivative · entry 6 Harrison Seth Loring · CIK 0001404955 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Apple Tree Partners IV, L. P Disclosed balance after: 0 Underlying: Common Stock · 7,617,746 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · kind: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · derivative.exercise_date: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · derivative.expiration_date: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F2 · ownership.nature: Apple Tree Partners IV, L.P. ("ATP IV"). ATP III GP, Ltd. ("ATP III"), is the sole general partner of ATP IV. Reporting Person is the sole director of ATP III and may be deemed to have sole voting and dispositive power over the shares held by ATP IV. Dr. Harrison disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 21, 2019 Filed Jun 21, 2019 21:01 UTC |
Harrison Seth LoringDirector · 10% owner
|
ConversionSeries A Convertible Preferred Stock · Derivative | 4,980,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013840 · doc1.xml · derivative · entry 5 Harrison Seth Loring · CIK 0001404955 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Apple Tree Partners IV, L. P Disclosed balance after: 0 Underlying: Common Stock · 4,980,168 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · kind: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · derivative.exercise_date: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · derivative.expiration_date: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F2 · ownership.nature: Apple Tree Partners IV, L.P. ("ATP IV"). ATP III GP, Ltd. ("ATP III"), is the sole general partner of ATP IV. Reporting Person is the sole director of ATP III and may be deemed to have sole voting and dispositive power over the shares held by ATP IV. Dr. Harrison disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 21, 2019 Filed Jun 21, 2019 21:01 UTC |
Harrison Seth LoringDirector · 10% owner
|
PurchaseCommon Stock | 1,388,889 | $18.00 | $25,000,002.00 |
DisclosureSEC source: 0001567619-19-013840 · doc1.xml · nonDerivative · entry 4 Harrison Seth Loring · CIK 0001404955 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Apple Tree Partners IV, L. P Disclosed balance after: 16,786,713 F2 · ownership.nature: Apple Tree Partners IV, L.P. ("ATP IV"). ATP III GP, Ltd. ("ATP III"), is the sole general partner of ATP IV. Reporting Person is the sole director of ATP III and may be deemed to have sole voting and dispositive power over the shares held by ATP IV. Dr. Harrison disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 21, 2019 Filed Jun 21, 2019 21:01 UTC |
Harrison Seth LoringDirector · 10% owner
|
ConversionCommon Stock | 2,799,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013840 · doc1.xml · nonDerivative · entry 3 Harrison Seth Loring · CIK 0001404955 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Apple Tree Partners IV, L. P Disclosed balance after: 15,397,824 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · price: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F2 · ownership.nature: Apple Tree Partners IV, L.P. ("ATP IV"). ATP III GP, Ltd. ("ATP III"), is the sole general partner of ATP IV. Reporting Person is the sole director of ATP III and may be deemed to have sole voting and dispositive power over the shares held by ATP IV. Dr. Harrison disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 21, 2019 Filed Jun 21, 2019 21:01 UTC |
Harrison Seth LoringDirector · 10% owner
|
ConversionCommon Stock | 7,617,746 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013840 · doc1.xml · nonDerivative · entry 2 Harrison Seth Loring · CIK 0001404955 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Apple Tree Partners IV, L. P Disclosed balance after: 12,597,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · price: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F2 · ownership.nature: Apple Tree Partners IV, L.P. ("ATP IV"). ATP III GP, Ltd. ("ATP III"), is the sole general partner of ATP IV. Reporting Person is the sole director of ATP III and may be deemed to have sole voting and dispositive power over the shares held by ATP IV. Dr. Harrison disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 21, 2019 Filed Jun 21, 2019 21:01 UTC |
Harrison Seth LoringDirector · 10% owner
|
ConversionCommon Stock | 4,980,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013840 · doc1.xml · nonDerivative · entry 1 Harrison Seth Loring · CIK 0001404955 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Apple Tree Partners IV, L. P Disclosed balance after: 4,980,168 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · price: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F2 · ownership.nature: Apple Tree Partners IV, L.P. ("ATP IV"). ATP III GP, Ltd. ("ATP III"), is the sole general partner of ATP IV. Reporting Person is the sole director of ATP III and may be deemed to have sole voting and dispositive power over the shares held by ATP IV. Dr. Harrison disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 21, 2019 Filed Jun 21, 2019 20:59 UTC |
ATP Life Science Ventures, L.P.10% owner
ATP III GP, Ltd.10% owner
|
ConversionSeries B Convertible Preferred Stock · Derivative | 2,799,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013838 · doc1.xml · derivative · entry 7 Apple Tree Partners IV, L.P. · CIK 0001593440 · 10% owner ATP III GP, Ltd. · CIK 0001593453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,799,910 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · kind: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · derivative.exercise_date: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · derivative.expiration_date: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F2 · ownership.direct: Apple Tree Partners IV, L.P. ("ATP IV"). ATP III GP, Ltd. ("ATP III"), is the sole general partner of ATP IV. Seth Harrison, a director of Issuer, is the sole director of ATP III and may be deemed to have sole voting and dispositive power over the shares held by ATP IV. Dr. Harrison disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 21, 2019 Filed Jun 21, 2019 20:59 UTC |
ATP Life Science Ventures, L.P.10% owner
ATP III GP, Ltd.10% owner
|
ConversionSeries A-2 Convertible Preferred Stock · Derivative | 7,617,746 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013838 · doc1.xml · derivative · entry 6 Apple Tree Partners IV, L.P. · CIK 0001593440 · 10% owner ATP III GP, Ltd. · CIK 0001593453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,617,746 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · kind: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · derivative.exercise_date: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · derivative.expiration_date: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F2 · ownership.direct: Apple Tree Partners IV, L.P. ("ATP IV"). ATP III GP, Ltd. ("ATP III"), is the sole general partner of ATP IV. Seth Harrison, a director of Issuer, is the sole director of ATP III and may be deemed to have sole voting and dispositive power over the shares held by ATP IV. Dr. Harrison disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 21, 2019 Filed Jun 21, 2019 20:59 UTC |
ATP Life Science Ventures, L.P.10% owner
ATP III GP, Ltd.10% owner
|
ConversionSeries A Convertible Preferred Stock · Derivative | 4,980,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013838 · doc1.xml · derivative · entry 5 Apple Tree Partners IV, L.P. · CIK 0001593440 · 10% owner ATP III GP, Ltd. · CIK 0001593453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,980,168 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · kind: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · derivative.exercise_date: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · derivative.expiration_date: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F2 · ownership.direct: Apple Tree Partners IV, L.P. ("ATP IV"). ATP III GP, Ltd. ("ATP III"), is the sole general partner of ATP IV. Seth Harrison, a director of Issuer, is the sole director of ATP III and may be deemed to have sole voting and dispositive power over the shares held by ATP IV. Dr. Harrison disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 21, 2019 Filed Jun 21, 2019 20:59 UTC |
ATP Life Science Ventures, L.P.10% owner
ATP III GP, Ltd.10% owner
|
PurchaseCommon Stock | 1,388,889 | $18.00 | $25,000,002.00 |
DisclosureSEC source: 0001567619-19-013838 · doc1.xml · nonDerivative · entry 4 Apple Tree Partners IV, L.P. · CIK 0001593440 · 10% owner ATP III GP, Ltd. · CIK 0001593453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,786,713 F2 · ownership.direct: Apple Tree Partners IV, L.P. ("ATP IV"). ATP III GP, Ltd. ("ATP III"), is the sole general partner of ATP IV. Seth Harrison, a director of Issuer, is the sole director of ATP III and may be deemed to have sole voting and dispositive power over the shares held by ATP IV. Dr. Harrison disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 21, 2019 Filed Jun 21, 2019 20:59 UTC |
ATP Life Science Ventures, L.P.10% owner
ATP III GP, Ltd.10% owner
|
ConversionCommon Stock | 2,799,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013838 · doc1.xml · nonDerivative · entry 3 Apple Tree Partners IV, L.P. · CIK 0001593440 · 10% owner ATP III GP, Ltd. · CIK 0001593453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,397,824 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · price: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F2 · ownership.direct: Apple Tree Partners IV, L.P. ("ATP IV"). ATP III GP, Ltd. ("ATP III"), is the sole general partner of ATP IV. Seth Harrison, a director of Issuer, is the sole director of ATP III and may be deemed to have sole voting and dispositive power over the shares held by ATP IV. Dr. Harrison disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 21, 2019 Filed Jun 21, 2019 20:59 UTC |
ATP Life Science Ventures, L.P.10% owner
ATP III GP, Ltd.10% owner
|
ConversionCommon Stock | 7,617,746 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013838 · doc1.xml · nonDerivative · entry 2 Apple Tree Partners IV, L.P. · CIK 0001593440 · 10% owner ATP III GP, Ltd. · CIK 0001593453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,597,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · price: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F2 · ownership.direct: Apple Tree Partners IV, L.P. ("ATP IV"). ATP III GP, Ltd. ("ATP III"), is the sole general partner of ATP IV. Seth Harrison, a director of Issuer, is the sole director of ATP III and may be deemed to have sole voting and dispositive power over the shares held by ATP IV. Dr. Harrison disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 21, 2019 Filed Jun 21, 2019 20:59 UTC |
ATP Life Science Ventures, L.P.10% owner
ATP III GP, Ltd.10% owner
|
ConversionCommon Stock | 4,980,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013838 · doc1.xml · nonDerivative · entry 1 Apple Tree Partners IV, L.P. · CIK 0001593440 · 10% owner ATP III GP, Ltd. · CIK 0001593453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,980,168 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F1 · price: The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019. F2 · ownership.direct: Apple Tree Partners IV, L.P. ("ATP IV"). ATP III GP, Ltd. ("ATP III"), is the sole general partner of ATP IV. Seth Harrison, a director of Issuer, is the sole director of ATP III and may be deemed to have sole voting and dispositive power over the shares held by ATP IV. Dr. Harrison disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 21, 2019 Filed Jun 24, 2019 22:23 UTC |
Redmile Group, LLC10% owner
Green Jeremy10% owner
|
ConversionSeries B Convertible Preferred Stock · Derivative | 671,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-032095 · tv524091_4.xml · derivative · entry 2 Redmile Group, LLC · CIK 0001425738 · 10% owner Green Jeremy · CIK 0001650527 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 671,808 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series B Convertible Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering on a 1-for-1 basis and had no expiration date. F1 · derivative.exercise_date: The Series B Convertible Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering on a 1-for-1 basis and had no expiration date. F1 · derivative.expiration_date: The Series B Convertible Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering on a 1-for-1 basis and had no expiration date. F2 · ownership.nature: These securities are directly owned by certain private investment vehicles managed by Redmile Group, LLC ("Redmile") and may be deemed beneficially owned by Redmile as investment manager of such private investment vehicles. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| June 21, 2019 Filed Jun 24, 2019 22:23 UTC |
Redmile Group, LLC10% owner
Green Jeremy10% owner
|
ConversionCommon Stock | 671,808 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-19-032095 · tv524091_4.xml · nonDerivative · entry 1 Redmile Group, LLC · CIK 0001425738 · 10% owner Green Jeremy · CIK 0001650527 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 671,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series B Convertible Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering on a 1-for-1 basis and had no expiration date. F2 · ownership.nature: These securities are directly owned by certain private investment vehicles managed by Redmile Group, LLC ("Redmile") and may be deemed beneficially owned by Redmile as investment manager of such private investment vehicles. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 13:50 UTC |
RTW INVESTMENTS, LP10% owner
WONG RODERICK10% owner
|
ConversionClass B Convertible Preferred · Derivative | 2,799,910 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-19-009471 · ownership.xml · derivative · entry 3 RTW INVESTMENTS, LP · CIK 0001493215 · 10% owner WONG RODERICK · CIK 0001493280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By RTW Disclosed balance after: 0 Underlying: Common Shares · 2,799,910 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class B Convertible Preferred converted into Common Shares, on a one-for-one basis, upon the closing of the Issuer's initial public offering, which occurred on June 19, 2019. F1 · price: Each share of Class B Convertible Preferred converted into Common Shares, on a one-for-one basis, upon the closing of the Issuer's initial public offering, which occurred on June 19, 2019. F1 · derivative.exercise_date: Each share of Class B Convertible Preferred converted into Common Shares, on a one-for-one basis, upon the closing of the Issuer's initial public offering, which occurred on June 19, 2019. F1 · derivative.expiration_date: Each share of Class B Convertible Preferred converted into Common Shares, on a one-for-one basis, upon the closing of the Issuer's initial public offering, which occurred on June 19, 2019. F2 · ownership.nature: The securities reported herein may be deemed beneficially owned by each of: (i) RTW Investments, LP ("RTW"), which is deemed the beneficial owner of shares held by RTW Master Fund, Ltd. and RTW Innovation Master Fund, Ltd. (the "Funds"), which are investment funds managed by RTW, and (ii) Roderick Wong, M.D who serves as the Managing Partner and Chief Investment Officer of RTW. Dr. Wong exercises voting and dispositive control over the securities held by RTW and is therefore deemed to be a beneficial owner of securities owned or controlled by RTW. Each of RTW and Dr. Wong disclaim beneficial ownership of the reported securities held by the Funds, except to the extent of its or his pecuniary interest therein. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 13:50 UTC |
RTW INVESTMENTS, LP10% owner
WONG RODERICK10% owner
|
PurchaseCommon Shares | 555,556 | $18.00 | $10,000,008.00 |
DisclosureSEC source: 0001493152-19-009471 · ownership.xml · nonDerivative · entry 2 RTW INVESTMENTS, LP · CIK 0001493215 · 10% owner WONG RODERICK · CIK 0001493280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By RTW Disclosed balance after: 3,355,466 F2 · ownership.nature: The securities reported herein may be deemed beneficially owned by each of: (i) RTW Investments, LP ("RTW"), which is deemed the beneficial owner of shares held by RTW Master Fund, Ltd. and RTW Innovation Master Fund, Ltd. (the "Funds"), which are investment funds managed by RTW, and (ii) Roderick Wong, M.D who serves as the Managing Partner and Chief Investment Officer of RTW. Dr. Wong exercises voting and dispositive control over the securities held by RTW and is therefore deemed to be a beneficial owner of securities owned or controlled by RTW. Each of RTW and Dr. Wong disclaim beneficial ownership of the reported securities held by the Funds, except to the extent of its or his pecuniary interest therein. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 13:50 UTC |
RTW INVESTMENTS, LP10% owner
WONG RODERICK10% owner
|
ConversionCommon Shares | 2,799,910 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-19-009471 · ownership.xml · nonDerivative · entry 1 RTW INVESTMENTS, LP · CIK 0001493215 · 10% owner WONG RODERICK · CIK 0001493280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By RTW Disclosed balance after: 2,799,910 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Class B Convertible Preferred converted into Common Shares, on a one-for-one basis, upon the closing of the Issuer's initial public offering, which occurred on June 19, 2019. F2 · ownership.nature: The securities reported herein may be deemed beneficially owned by each of: (i) RTW Investments, LP ("RTW"), which is deemed the beneficial owner of shares held by RTW Master Fund, Ltd. and RTW Innovation Master Fund, Ltd. (the "Funds"), which are investment funds managed by RTW, and (ii) Roderick Wong, M.D who serves as the Managing Partner and Chief Investment Officer of RTW. Dr. Wong exercises voting and dispositive control over the securities held by RTW and is therefore deemed to be a beneficial owner of securities owned or controlled by RTW. Each of RTW and Dr. Wong disclaim beneficial ownership of the reported securities held by the Funds, except to the extent of its or his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.